Abstract PS4-07-18: Association of tumor-infiltrating lymphocytes (TILs) with outcomes in patients with early TNBC treated with neoadjuvant chemotherapy with or without pembrolizumab
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: R. S. Lee, Q. Jin, B. Binboga Kurt, B. Koca, J. Gomez Tejeda Zanudo, A. Patel, A. Barkell, J. Baginska, O. M. Cunningham, C. E. Stever, T. S. Parker, T. Rahman, M. Luo, I. G. Martino, B. M. Drummey, S. A. Virani, K. Santos, J. Bsat, C. Snow, N. Tung, S. Lo, M. G. Faggen, N. Sinclair, N. Ahmad, M. Constantinou, S. Sinclair, J. L. Meisel, S. A. Kirschner, T. A. King, R. Salgado, E. A. Mittendorf, N. U. Lin, N. Tayob, E. P. Winer, E. C. de Bruin, S. M. Tolaney, A. Moeini, A. C. Garrido-Castro
Institutions: Dana-Farber Cancer Institute, Mass General Brigham, AstraZeneca (United Kingdom), Beth Israel Deaconess Medical Center, Stamford Hospital, South Shore Hospital, Dana-Farber Brigham Cancer Center, Berkshire Medical Center, Berkshire Health Systems, Brown University, Winship Cancer Institute, Brigham and Women's Hospital, Ziekenhuis aan de Stroom, Yale Cancer Center, Yale University, AstraZeneca (Spain)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129446141
Cites:
Cited by:
Related to: